Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Humaidan

Showing results (181-190 of 262) with videos related to

Pageof 27
Sort By:
Reproductive Biomedicine Online|May 24, 2017
Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled studyBirgit Alsbjerg, Helle Olesen Elbaek, Rita Jakubcionyte Laursen, et al.
International Journal of Molecular Sciences|November 13, 2025
Urine Progesterone Level as a Diagnostics Tool to Evaluate the Need for Luteal Phase Rescue in Hormone Replacement Therapy Frozen Embryo Transfer CyclesLinette Yde Hansen, Takeshi Fujisawa, Betina Boel Povlsen, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 16, 2017
Separation and characterization of maternal cardiac and vascular sounds in the third trimester of pregnancyDiana Riknagel, Henrik Zimmermann, Richard Farlie, et al.
Fertility and Sterility|April 24, 2017
Fertility preservation and refreezing of transplanted ovarian tissue-a potential new way of managing patients with low risk of malignant cell recurrenceStine Gry Kristensen, Veronica Giorgione, Peter Humaidan, et al.
Fertility and Sterility|February 19, 2014
Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocolHuman Mousavi Fatemi, Biljana Popovic-Todorovic, Peter Humaidan, et al.
Fertility and Sterility|November 3, 2015
Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding studyThi Ngoc Lan Vuong, Manh Tuong Ho, Tan Duc Ha, et al.
Human Reproduction (Oxford, England)|July 26, 2015
Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trialClaus Yding Andersen, Helle Olesen Elbaek, Birgit Alsbjerg, et al.
Human Reproduction (Oxford, England)|January 23, 2020
The early luteal hormonal profile in IVF patients triggered with hCGLan N Vuong, Tuong M Ho, Toan D Pham, et al.
Panminerva Medica|July 3, 2018
Freeze-all strategy in IVF/ICSI cycles: an update on clinical utilityMatheus Roque, Beatrice Nuto Nóbrega, Marcello Valle, et al.
Fertility and Sterility|April 23, 2013
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center studyNikolaos P Polyzos, Scott M Nelson, Dominic Stoop, et al.
Pageof 27

Showing results (181-190 of 262) with videos related to

Sort By:
Pageof 27
Reproductive Biomedicine Online|May 24, 2017
Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled studyBirgit Alsbjerg, Helle Olesen Elbaek, Rita Jakubcionyte Laursen, et al.
International Journal of Molecular Sciences|November 13, 2025
Urine Progesterone Level as a Diagnostics Tool to Evaluate the Need for Luteal Phase Rescue in Hormone Replacement Therapy Frozen Embryo Transfer CyclesLinette Yde Hansen, Takeshi Fujisawa, Betina Boel Povlsen, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 16, 2017
Separation and characterization of maternal cardiac and vascular sounds in the third trimester of pregnancyDiana Riknagel, Henrik Zimmermann, Richard Farlie, et al.
Fertility and Sterility|April 24, 2017
Fertility preservation and refreezing of transplanted ovarian tissue-a potential new way of managing patients with low risk of malignant cell recurrenceStine Gry Kristensen, Veronica Giorgione, Peter Humaidan, et al.
Fertility and Sterility|February 19, 2014
Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocolHuman Mousavi Fatemi, Biljana Popovic-Todorovic, Peter Humaidan, et al.
Fertility and Sterility|November 3, 2015
Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding studyThi Ngoc Lan Vuong, Manh Tuong Ho, Tan Duc Ha, et al.
Human Reproduction (Oxford, England)|July 26, 2015
Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trialClaus Yding Andersen, Helle Olesen Elbaek, Birgit Alsbjerg, et al.
Human Reproduction (Oxford, England)|January 23, 2020
The early luteal hormonal profile in IVF patients triggered with hCGLan N Vuong, Tuong M Ho, Toan D Pham, et al.
Panminerva Medica|July 3, 2018
Freeze-all strategy in IVF/ICSI cycles: an update on clinical utilityMatheus Roque, Beatrice Nuto Nóbrega, Marcello Valle, et al.
Fertility and Sterility|April 23, 2013
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center studyNikolaos P Polyzos, Scott M Nelson, Dominic Stoop, et al.
Pageof 27